A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-Risk Populations in Kenya, Africa

This study has been completed.

Sponsor:

Information provided by:

International AIDS Vaccine Initiative

ClinicalTrials.gov Identifier:

NCT00971230

First received: September 2, 2009

Last updated: August 5, 2010

Last verified: August 2010

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	July 2010
Primary Completion Date:	June 2010 (Final data collection date for primary outcome measure)

No publications provided by International AIDS Vaccine Initiative

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Mutua G, Sanders E, Mugo P, Anzala O, Haberer JE, Bangsberg D, Barin B, Rooney JF, Mark D, Chetty P, Fast P, Priddy FH. Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers. PLoS One. 2012;7(4):e33103. Epub 2012 Apr 12.

To Top